Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
20.23
+0.85 (4.39%)
May 27, 2026, 1:33 PM EDT - Market open

Denali Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Maintains
$40$35
BuyMaintains$40$35+73.01%May 26, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 22, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 22, 2026
Unknown Analyst
Jefferies
No rating
Jefferies
Buy
Maintains
$40
BuyMaintains$40+97.73%May 22, 2026
Deutsche Bank
Deutsche Bank
Buy
Maintains
$35$31
BuyMaintains$35$31+53.24%May 22, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$42
BuyMaintains$42+107.61%May 22, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$35$40
BuyMaintains$35$40+97.73%May 11, 2026
BTIG
BTIG
Buy
Maintains
$39
BuyMaintains$39+92.78%May 11, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.